6:53 PM Feb 16, 2018

Necessary adjustment

Changing a pivotal trial’s primary endpoint analysis after the study is under way is usually not a good sign. So when Bristol-Myers Squibb Co. revealed top-line results from the CheckMate -227...

6:09 PM Feb 16, 2018

FDA’s bigger piggy bank

FDA plans to use a proposed record-setting funding boost to invest in projects it believes could lead to fundamental improvements in the way medical products are tested, reviewed and manufactured....

4:24 PM Feb 16, 2018

This year’s model

Companies are answering FDA’s push for model-informed dose optimization in cancer by modeling how tumors grow and how tumor kinetics relate to outcomes. The models can support dosing decisions...

5:19 PM Feb 15, 2018

Banking on the placenta

Celgene Corp. spinout Celularity Inc. is aiming to disrupt the stem cell market with a platform of placenta-based cell therapies whose intrinsic allo-tolerance could provide a broadly applicable...

5:09 PM Feb 15, 2018

Pfizer’s chemistry machine

With the goal of creating a step-change in the optimization of small molecules in discovery research, Pfizer Inc. has built a continuous flow machine that rapidly tests thousands of chemical...

1
2
3
4
5

Latest News

4:15 PM Feb 20, 2018

Takeda, Wave in CNS nucleic acid deal

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) and Wave Life Sciences Ltd. (NASDAQ:WVE) partnered to develop...

4:06 PM Feb 20, 2018

Eli Lilly stops Phase II trial of BTK inhibitor in RA

Eli Lilly and Co. (NYSE:LLY) discontinued the Phase II RAjuvenate trial of HM71224 (LY3337641) to treat...

3:57 PM Feb 20, 2018

JNJ execs launch Centyrins newco Aro

Two former Johnson & Johnson (NYSE:JNJ) executives have co-founded Aro Biotherapeutics Co. (...

3:53 PM Feb 20, 2018

Management tracks: Cell Medica, Iterum

Cancer immunotherapy company Cell Medica Ltd. (London, U.K.) appointed Kevin Boyle as CFO. He was CFO at...

3:46 PM Feb 20, 2018

Everest gets rights to Tetraphase antibiotic

Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH) granted C-Bridge-backed Everest Medicines Ltd. (Boston,...

3:06 PM Feb 20, 2018

Aimmune's peanut allergy therapy meets in Phase III

Aimmune Therapeutics Inc. (NASDAQ:AIMT) said AR101 met the primary endpoint in the Phase III PALISADE...

2:35 PM Feb 20, 2018

Voyager, AbbVie partner for AD gene therapies

Gene therapy company Voyager Therapeutics Inc. (NASDAQ:VYGR) jumped $4.30 (22%) to $23.66 on Tuesday after...

2:09 PM Feb 20, 2018

MiMedx falls on delayed earnings filing due to internal audit

Regenerative medicines company MiMedx Group Inc. (NASDAQ:MDXG) fell $5.72 (40%) to $8.75 on Tuesday after...

1:48 PM Feb 20, 2018

Ionis, AstraZeneca in antisense kidney disease deal

Ionis Pharmaceuticals Inc. (NASDAQ:IONS) granted AstraZeneca plc (LSE:AZN; NYSE:AZN) worldwide rights to...

1:10 PM Feb 20, 2018

New compound kills tumor cells with spliceosome mutations

In a Nature Medicine study, researchers at H3 Biomedicine Inc. (Cambridge, Mass.) described development...

9:29 AM Feb 20, 2018

Arix, Fosun in China-focused deal

Life sciences investment firm Arix Bioscience plc (LSE:ARIX) partnered with Fosun International Ltd. (HKSE:...

8:41 AM Feb 20, 2018

Taiwan Liposome planning NASDAQ listing

Taiwan Liposome Co. Ltd. (TPEx:4152) proposed to raise up to $50 million through the sale of ADSs in a...

7:10 AM Feb 20, 2018

Organ-on-chip company Emulate reveals new deals

Emulate Inc. (Cambridge, Mass.) announced partnerships with Roche (SIX:ROG; OTCQX:RHHBY) and Takeda...

4:42 PM Feb 16, 2018

Stem cell-based vaccine could give broad immunity against cancers

A Stanford University team published a paper in Cell Stem Cell showing a stem cell-based vaccine prevented...

4:27 PM Feb 16, 2018

FDA grants EAP designation to Guardant's NGS-based liquid biopsy

Guardant Health Inc. (Redwood City, Calif.) said FDA granted Expedited Access Pathway (EAP) designation to...

4:23 PM Feb 16, 2018

FDA to hold patient meeting on opioid use disorder

FDA is asking individuals with opioid use disorder to testify at a public meeting April 17. The event is...

4:21 PM Feb 16, 2018

FDA approves Imfinzi for NSCLC that has not progressed

FDA approved Imfinzi durvalumab from AstraZeneca plc (LSE:AZN; NYSE:AZN) to treat stage III unresectable...

4:20 PM Feb 16, 2018

Addex proposes CHF40M private placement

Addex Therapeutics Ltd. (SIX:ADXN) proposed Thursday to raise up to CHF40 million ($42.7 million) through...

4:08 PM Feb 16, 2018

Alkermes hits high following IL-2 deal

Alkermes plc (NASDAQ:ALKS) hit a 52-week high of $71.22 on Friday on the heels of Wednesday's multibillion...

3:49 PM Feb 16, 2018

Improved dopamine receptor agonists for Parkinson’s

A study published in Nature Communications showed that non-catechol dopamine D1 receptor agonists reduced...

Down Up